 Novavax, Inc. NASDAQ: NVAX, Orphazyme AS NASDAQ: ORPH and Avenue Therapeutics, Inc. NASDAQ: ATXI are among the biggest movers among biopharma stocks Monday. Novavax Finally Releases Phase 3 COVID-19 Results: After a protracted delay, Gaithersburg, Maryland-based Novavax reported preliminary results showing its coronavirus candidate NVX-CoV2371 met the primary endpoint of the Phase 3 PREVENT trial in the U.S. and Mexico. 